Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Frequency Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-18Dec-31-17
   S-1/AS-1/A
Revenues   [+]11.912.0
            Revenue growth  -0.7% 
Cost of goods sold  18.916.3
Gross profit  -7.1-4.3
            Gross margin  -59.5%-36.3%
Selling, general and administrative   [+]7.14.3
Other operating expenses  4.87.6
EBITDA   [+]-18.3-15.8
            EBITDA margin  -154.0%-131.8%
Depreciation and amortization  0.70.5
EBIT   [+]-18.9-16.3
            EBIT margin  -159.5%-136.3%
Interest expense  0.10.2
Other income (expense), net   [+]19.116.5
Pre-tax income  0.00.0
Income taxes  0.00.0
Net income  0.00.0
            Net margin  0.0%0.0%
   
Basic EPS  $0.00$0.00
Diluted EPS  $0.00$0.00
   
Shares outstanding (basic)   [+]1,530.2702.9
Shares outstanding (diluted)   [+]1,530.2702.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy